Management of Post-Traumatic Intracranial Bleeding with Incidental Stroke Finding
Do not start aspirin while active intracranial bleeding is present; wait until the traumatic ICB has stabilized on repeat imaging (typically 24-48 hours), then initiate aspirin for secondary stroke prevention once bleeding risk has resolved. 1
Immediate Management of Active Traumatic ICB
Hold All Antiplatelet Therapy During Active Bleeding
- Aspirin must be withheld during the acute phase of traumatic intracranial bleeding, regardless of the incidental stroke finding 1
- The bleeding risk from active traumatic ICB outweighs stroke prevention benefits in the immediate post-injury period 1
- Monitor hemoglobin levels and vital signs to ensure hemodynamic stability during the observation period 1
Imaging Protocol for Traumatic ICB
- Obtain repeat head CT at 24-48 hours to assess for progression of intracranial hemorrhage 2
- Patients with stable or improving ICB on repeat imaging can be considered for aspirin initiation 2
- If ICB progresses on repeat imaging, continue to hold aspirin and repeat CT in another 24-48 hours 3
Timing of Aspirin Initiation for Stroke Prevention
When to Start Aspirin
- Resume aspirin 24-48 hours after traumatic ICB has stabilized on repeat CT imaging 1, 2
- Start with aspirin 75-100 mg daily (not 325 mg loading dose) once bleeding has resolved 1
- Do not use loading doses when initiating therapy after intracranial bleeding 1
Evidence Supporting Early Aspirin After Stabilization
- Low-dose aspirin (81 mg) does not increase progression of traumatic ICB once initial bleeding has stabilized 2, 4
- Aspirin started within 48 hours of ischemic stroke reduces early recurrent stroke by 10 per 1,000 patients without significantly increasing intracranial hemorrhage 5
- The stroke prevention benefit outweighs minor bleeding risks once active hemorrhage has resolved 1
Long-Term Secondary Stroke Prevention Strategy
Antiplatelet Regimen Selection
- For asymptomatic incidental stroke: aspirin 75-325 mg daily is the recommended first-line therapy 6
- Aspirin monotherapy is preferred over anticoagulation for secondary stroke prevention in arterial (non-cardiac) stroke 6, 7
- Alternative options include clopidogrel 75 mg daily or aspirin 25 mg plus extended-release dipyridamole 200 mg twice daily if aspirin is not tolerated 6
What NOT to Do
- Never use warfarin or other anticoagulation for secondary prevention of arterial stroke - it increases major bleeding (including intracranial hemorrhage) without improving outcomes compared to aspirin 6, 7
- Do not use dual antiplatelet therapy (aspirin plus clopidogrel) beyond 90 days - this increases bleeding risk without additional stroke prevention benefit in stable patients 6
- Avoid high-intensity anticoagulation (INR 3.0-4.5) which caused excess intracranial hemorrhage and death in arterial stroke patients 7
Risk Factor Management Alongside Aspirin
Blood Pressure Control
- Target systolic blood pressure <140 mm Hg for long-term stroke prevention 6
- Aggressive BP control reduces recurrent stroke risk even in patients with large vessel disease 6
Lipid Management
- Initiate high-intensity statin therapy targeting LDL <70 mg/dL 6
- Lower LDL levels are associated with reduced vascular events in stroke patients 6
Monitoring After Aspirin Initiation
Short-Term Surveillance
- Check hemoglobin 24-48 hours after starting aspirin to ensure no occult bleeding 1
- Monitor for signs of recurrent intracranial bleeding for 72 hours 1
- Repeat neurological examination to detect any new deficits 1
Long-Term Management
- Maintain lifelong antiplatelet therapy for secondary stroke prevention 1, 6
- Antiplatelet therapy reduces recurrent stroke, MI, and vascular death even in patients with prior bleeding events 1
- Counsel patients not to stop therapy for minor bleeding or bruising without physician consultation 1
Common Pitfalls to Avoid
- Do not permanently withhold aspirin due to the traumatic ICB - once stabilized, the stroke prevention benefit outweighs bleeding risk 1, 2, 4
- Do not delay aspirin indefinitely waiting for "complete resolution" of ICB on imaging - stability (not complete resolution) is the threshold 2
- Do not use platelet transfusions in aspirin-treated patients with traumatic ICB - they do not improve platelet function or prevent ICB progression 3
- Avoid routine repeat head CTs beyond the initial 24-48 hour scan in stable patients on low-dose aspirin - this is not cost-effective and does not change management 2